Fibrates reduce atherosclerosis and cardiovascular disease events. A major mechanism of this
benefit appears to be their ability to raise plasma high density lipoprotein cholesterol
(HDL-C), especially in patients with high triglyceride levels. This study will investigate
the effects of the addition of Trilipix (fenofibric acid) versus placebo to ongoing statin
treatment on high density lipoprotein (HDL) composition and arterial function in subjects
with insulin resistance.